Author:
Ikeda Keiro,Ichikawa Tomotsugu,Wakimoto Hiroaki,Silver Jonathan S.,Deisboeck Thomas S.,Finkelstein Dianne,Harsh Griffith R.,Louis David N.,Bartus Raymond T.,Hochberg Fred H.,Chiocca E. Antonio
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference38 articles.
1. Schuler, M. et al. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum. Gene Ther. 9, 2075–2082 (1998).
2. Chase, M., Chung, R.Y. & Chiocca, E.A. An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy. Nature Biotechnol. 16, 444–448 (1998).
3. Bui, L.A. et al. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2. Hum. Gene Ther. 8, 2173–2182 (1997).
4. Martuza, R.L., Malick, A., Markert, J.M., Ruffner, K.I. & Coen, D.M. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252, 854–856 (1991).
5. Boviatsis, E.J. et al. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res. 54, 5745–5751 (1994).
Cited by
288 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献